Edition:
United States

DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

118.59USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$118.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,307,847
52-wk High
$156.16
52-wk Low
$85.76

About

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The... (more)

Overall

Beta: 0.22
Market Cap(Mil.): $4,132.42
Shares Outstanding(Mil.): 86.56
Dividend: --
Yield (%): --

Financials

  DXCM.O Industry Sector
P/E (TTM): -- 32.13 32.55
EPS (TTM): -0.77 -- --
ROI: -13.69 13.70 13.82
ROE: -21.66 16.39 15.24

Diabetes care firm Dexcom loses bid to narrow AgaMatrix's patent case

Diabetes management company DexCom Inc on Wednesday lost a bid to narrow a patent infringement case brought against it by rival WaveForm Technologies Inc, a subsidiary of AgaMatrix Holdings LLC.

Apr 03 2019

Earnings vs. Estimates